Safety and effectiveness of kidney transplantation using a donation after brain death donor with acute kidney injury: a retrospective cohort study

Abstract The use of kidneys from donation after brain death (DBD) donors with acute kidney injury (AKI) is a strategy to expand the donor pool. The aim of this study was to evaluate how kidney transplantation (KT) from a donor with AKI affects long-term graft survival in various situations. All pati...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kyeong Deok Kim, Kyo Won Lee, Sang Jin Kim, Okjoo Lee, Manuel Lim, Eun Sung Jeong, Jieun Kwon, Jaehun Yang, Jongwook Oh, Jae Berm Park
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/42472adc0d3d419b8acb4ae83f9cbfa0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:42472adc0d3d419b8acb4ae83f9cbfa0
record_format dspace
spelling oai:doaj.org-article:42472adc0d3d419b8acb4ae83f9cbfa02021-12-02T11:35:41ZSafety and effectiveness of kidney transplantation using a donation after brain death donor with acute kidney injury: a retrospective cohort study10.1038/s41598-021-84977-12045-2322https://doaj.org/article/42472adc0d3d419b8acb4ae83f9cbfa02021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-84977-1https://doaj.org/toc/2045-2322Abstract The use of kidneys from donation after brain death (DBD) donors with acute kidney injury (AKI) is a strategy to expand the donor pool. The aim of this study was to evaluate how kidney transplantation (KT) from a donor with AKI affects long-term graft survival in various situations. All patients who underwent KT from DBD donors between June 2003 and April 2016 were retrospectively reviewed. The KDIGO (Kidney Disease: Improving Global Outcomes) criteria were used to classify donor AKI. The cohort included 376 donors (no AKI group, n = 117 [31.1%]; AKI group n = 259 [68.9%]). Death-censored graft survival was similar according to the presence of AKI, AKI severity, and the AKI trend (p = 0.929, p = 0.077, and p = 0.658, respectively). Patients whose donors had AKI who received using low dose (1.5 mg/kg for three days) rabbit anti-thymocyte globulin (r-ATG) as the induction agent had significantly superior death-censored graft survival compared with patients in that group who received basiliximab (p = 0.039). AKI in DBD donors did not affect long-term death-censored graft survival. Low-dose r-ATG may be considered as an induction immunosuppression in recipients receiving kidneys with AKI because it showed better graft survival than basiliximab.Kyeong Deok KimKyo Won LeeSang Jin KimOkjoo LeeManuel LimEun Sung JeongJieun KwonJaehun YangJongwook OhJae Berm ParkNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Kyeong Deok Kim
Kyo Won Lee
Sang Jin Kim
Okjoo Lee
Manuel Lim
Eun Sung Jeong
Jieun Kwon
Jaehun Yang
Jongwook Oh
Jae Berm Park
Safety and effectiveness of kidney transplantation using a donation after brain death donor with acute kidney injury: a retrospective cohort study
description Abstract The use of kidneys from donation after brain death (DBD) donors with acute kidney injury (AKI) is a strategy to expand the donor pool. The aim of this study was to evaluate how kidney transplantation (KT) from a donor with AKI affects long-term graft survival in various situations. All patients who underwent KT from DBD donors between June 2003 and April 2016 were retrospectively reviewed. The KDIGO (Kidney Disease: Improving Global Outcomes) criteria were used to classify donor AKI. The cohort included 376 donors (no AKI group, n = 117 [31.1%]; AKI group n = 259 [68.9%]). Death-censored graft survival was similar according to the presence of AKI, AKI severity, and the AKI trend (p = 0.929, p = 0.077, and p = 0.658, respectively). Patients whose donors had AKI who received using low dose (1.5 mg/kg for three days) rabbit anti-thymocyte globulin (r-ATG) as the induction agent had significantly superior death-censored graft survival compared with patients in that group who received basiliximab (p = 0.039). AKI in DBD donors did not affect long-term death-censored graft survival. Low-dose r-ATG may be considered as an induction immunosuppression in recipients receiving kidneys with AKI because it showed better graft survival than basiliximab.
format article
author Kyeong Deok Kim
Kyo Won Lee
Sang Jin Kim
Okjoo Lee
Manuel Lim
Eun Sung Jeong
Jieun Kwon
Jaehun Yang
Jongwook Oh
Jae Berm Park
author_facet Kyeong Deok Kim
Kyo Won Lee
Sang Jin Kim
Okjoo Lee
Manuel Lim
Eun Sung Jeong
Jieun Kwon
Jaehun Yang
Jongwook Oh
Jae Berm Park
author_sort Kyeong Deok Kim
title Safety and effectiveness of kidney transplantation using a donation after brain death donor with acute kidney injury: a retrospective cohort study
title_short Safety and effectiveness of kidney transplantation using a donation after brain death donor with acute kidney injury: a retrospective cohort study
title_full Safety and effectiveness of kidney transplantation using a donation after brain death donor with acute kidney injury: a retrospective cohort study
title_fullStr Safety and effectiveness of kidney transplantation using a donation after brain death donor with acute kidney injury: a retrospective cohort study
title_full_unstemmed Safety and effectiveness of kidney transplantation using a donation after brain death donor with acute kidney injury: a retrospective cohort study
title_sort safety and effectiveness of kidney transplantation using a donation after brain death donor with acute kidney injury: a retrospective cohort study
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/42472adc0d3d419b8acb4ae83f9cbfa0
work_keys_str_mv AT kyeongdeokkim safetyandeffectivenessofkidneytransplantationusingadonationafterbraindeathdonorwithacutekidneyinjuryaretrospectivecohortstudy
AT kyowonlee safetyandeffectivenessofkidneytransplantationusingadonationafterbraindeathdonorwithacutekidneyinjuryaretrospectivecohortstudy
AT sangjinkim safetyandeffectivenessofkidneytransplantationusingadonationafterbraindeathdonorwithacutekidneyinjuryaretrospectivecohortstudy
AT okjoolee safetyandeffectivenessofkidneytransplantationusingadonationafterbraindeathdonorwithacutekidneyinjuryaretrospectivecohortstudy
AT manuellim safetyandeffectivenessofkidneytransplantationusingadonationafterbraindeathdonorwithacutekidneyinjuryaretrospectivecohortstudy
AT eunsungjeong safetyandeffectivenessofkidneytransplantationusingadonationafterbraindeathdonorwithacutekidneyinjuryaretrospectivecohortstudy
AT jieunkwon safetyandeffectivenessofkidneytransplantationusingadonationafterbraindeathdonorwithacutekidneyinjuryaretrospectivecohortstudy
AT jaehunyang safetyandeffectivenessofkidneytransplantationusingadonationafterbraindeathdonorwithacutekidneyinjuryaretrospectivecohortstudy
AT jongwookoh safetyandeffectivenessofkidneytransplantationusingadonationafterbraindeathdonorwithacutekidneyinjuryaretrospectivecohortstudy
AT jaebermpark safetyandeffectivenessofkidneytransplantationusingadonationafterbraindeathdonorwithacutekidneyinjuryaretrospectivecohortstudy
_version_ 1718395816981299200